Demergers & amalgamations

Every company here filed a step of a scheme of arrangement inside the window: a demerger or amalgamation approved by the board, an exchange observation letter, a court-convened shareholder or creditor meeting, the NCLT's sanction, or the record date that makes it real. The filing on each row shows which stage the scheme has reached.

CompanyWhy it’s here — the filingReaction 1d / 1w / 1mPriceMcapP/EROCERev YoY
Belrise IndustriesAuto Components & EquipmentsBelrise gets no adverse observations from NSE and BSE for merger scheme4 Jul 2026Nclt Scheme Filed-0.5% +1.3% +5.6%₹24121,461 Cr40.3vs 26.210.9%+12.6%
DR Agarwals Health Care LHospitalUnsecured creditors approve Dr Agarwal Eye Hospital merger scheme2 Jul 2026Nclt Scheme Filed×7+0.6% +2.3% +1.3%₹48915,514 Cr104.3vs 47.17.1%+26.0%
DR. Agarwal's Eye Hosp LHospitalUnsecured creditors approve amalgamation with Health Care arm2 Jul 2026Nclt Scheme Filed×6-0.7% -0.2% +0.3%₹5,3002,560 Cr36.0vs 47.114.3%+20.2%
GSP Crop SciencePesticides & AgrochemicalsBoard approves scheme to merge subsidiaries and demerge manufacturing unit2 Jul 2026Nclt Scheme Filed×2+1.7% +10.8% +49.3%₹4942,299 Cr52.7vs 19.915.6%
Man Coat Metal & IndIron & Steel ProductsMinutes of Court Convened General Meeting submitted to exchange2 Jul 2026Nclt Scheme Filed×4+3.5% +12.2% +4.8%₹1351,444 Cr32.4vs 15.912.1%+4.9%
Basf IndiaSpecialty ChemicalsBASF India NCLT meeting approves 1:1 demerger of agri business into BASIL2 Jul 2026Demerger Ratio AnnouncedNclt Scheme Filed×3+2.8% -2.0% +3.9%₹3,67015,888 Cr24.7vs 23.712.7%+24.5%
Arihant Capital MKTSStockbroking & AlliedBSE, NSE give no objection to Arihant Capital composite scheme of arrangement1 Jul 2026Nclt Scheme Filed×3+2.8% +6.6% +11.3%₹81.64895 Cr22.0vs 15.3+53.5%
Jhaveri Credits & CapitalOther Financial ServicesPromoter group acquires 10.62% stake via amalgamation scheme1 Jul 2026Nclt Scheme Filed×3-3.9% -6.3% -10.2%₹208230 Cr82.7vs 18.41.3%
Maithan AlloysFerro & Silica ManganeseUpdate on merger scheme with Impex Metal & Ferro Alloys1 Jul 2026Nclt Scheme Filed×2+0.1% +1.6% -5.0%₹9992,909 Cr10.0vs 11.113.9%-14.7%
NiitEducationAmalgamation scheme with NIFB Training and RPS Consulting becomes effective from July 1, 20261 Jul 2026Nclt Scheme Filed×2+3.8% +0.0% -4.0%₹90.51,237 Cr137.1vs 22.31.1%+13.7%
Expo Engineering And ProjectsOther Industrial ProductsBoard approves draft merger scheme absorbing EP into Expo Engineering30 Jun 2026Nclt Scheme Filed-0.4% +11.0% +8.1%₹91.03211 Cr72.3vs 19.05.6%-56.6%
Autoline IndustriesAUTOINDAccounting amendments to Autoline Design Software merger scheme30 Jun 2026Nclt Scheme Filed×2-1.8% +12.3% +2.5%₹84.56384 Cr9.613.1%+74.7%
PricolAuto Components & EquipmentsPricol Board approves demerger of DICVS business into Pricol Autotech27 Jun 2026Demerger Ratio Announced×2+3.3% +4.4% +13.1%₹7589,238 Cr34.5vs 26.223.6%+23.5%
Ipca LaboratoriesPharmaceuticalsIpca Labs board approves merger of Krebs Biochemicals26 Jun 2026Nclt Scheme Filed×2+5.4% +8.9% +9.6%₹2,00650,902 Cr38.9vs 29.615.6%+20.8%
Apollo Hospitals Enter. LHospitalNCLT meetings approve Apollo Hospitals composite scheme of arrangement26 Jun 2026Nclt Scheme Filed×4+1.6% +1.9% +4.0%₹8,9301.28 L Cr61.4vs 47.116.6%+20.6%
Magellanic CloudComputers - Software & ConsultingMagellanic Cloud board approves merger of wholly owned subsidiary IVIS International25 Jun 2026Nclt Scheme Filed+13.1% +8.7% +9.5%₹24.961,470 Cr10.5vs 16.116.7%+9.9%
RPSG VenturesBusiness Process Outsourcing (BPO)/ Knowledge Process Outsourcing (KPO)RPSG Ventures buys Clarionix Healthcare, board approves composite scheme25 Jun 2026Demerger Ratio Announced×4-5.1% +2.9% +5.7%₹8452,796 Cr1.6%+20.4%
Page 4 of 4Previous
How this list is built

A company appears when an NSE/BSE filing inside the last 90 days carries one of these classifier signals (minimum importance: Medium): Nclt Scheme Filed, Demerger Ratio Announced. Each row shows the latest qualifying filing; the reaction columns are the stock’s measured move 1 day, 1 week and 1 month after that filing.

MarketPing publishes facts, filings and measured history only — nothing on this page is investment advice, a recommendation or a rating.